Upstream Bio, Inc.

UPBNasdaq· Pharmaceutical Preparations

Price History

Revenue

$2.9M

▲ 20.4% YoY

Net Income

-$143.4M

▼ 128.4% YoY

EPS

$-2.66

▲ 52.3% YoY

Cash

$101.6M

▼ 68.8% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.